[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

CRSP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $7,516,500.00

CRISPR Therapeutics Insider Trading History Chart

CRISPR Therapeutics Share Price & Price History

^$69.09

▼ -1.57 (-2.22%)

As of 11/29/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

CRISPR Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/30/2023	Samarth Kulkarni	CEO	Sell	25,000	$64.88	$1,622,000.00	387,377
4/25/2023	Samarth Kulkarni	CEO	Sell	25,000	$50.67	$1,266,750.00	387,377
3/29/2023	Samarth Kulkarni	CEO	Sell	25,000	$44.46	$1,111,500.00	387,377
2/27/2023	Samarth Kulkarni	CEO	Sell	25,000	$48.25	$1,206,250.00	375,988
1/27/2023	Samarth Kulkarni	CEO	Sell	25,000	$51.47	$1,286,750.00	369,111
12/28/2022	Samarth Kulkarni	CEO	Sell	25,000	$40.93	$1,023,250.00	369,111
11/28/2022	Samarth Kulkarni	CEO	Sell	25,000	$54.03	$1,350,750.00	290,279
10/26/2022	Samarth Kulkarni	CEO	Sell	25,000	$54.81	$1,370,250.00	290,279
9/28/2022	Samarth Kulkarni	CEO	Sell	25,000	$64.61	$1,615,250.00	290,279
8/29/2022	Samarth Kulkarni	CEO	Sell	25,000	$66.84	$1,671,000.00	290,279
7/27/2022	Samarth Kulkarni	CEO	Sell	25,000	$75.91	$1,897,750.00	290,279
6/29/2022	Samarth Kulkarni	CEO	Sell	25,000	$61.59	$1,539,750.00	290,279
8/6/2021	Michael John Tomsicek	CFO	Sell	25,000	$138.52	$3,463,000.00	26,891
8/4/2021	Samarth Kulkarni	CEO	Sell	1,500	$125.02	$187,530.00	189,219
7/19/2021	Bradley J. Bolzon	Director	Sell	10,000	$126.43	$1,264,300.00
6/30/2021	Rodger Novak	President	Sell	25,000	$165.00	$4,125,000.00	573,007
6/28/2021	Bradley J. Phd Bolzon	Director	Sell	20,375	$152.48	$3,106,780.00	17,159
6/21/2021	Rodger Novak	President	Sell	25,000	$128.62	$3,215,500.00	646,836
6/15/2021	Samarth Kulkarni	CEO	Sell	30,000	$126.43	$3,792,900.00	217,719
6/11/2021	Bradley J. Bolzon	Director	Sell	10,000	$126.61	$1,266,100.00	24,948
3/22/2021	Bradley J. Bolzon	Director	Sell	30,374	$132.37	$4,020,606.38	57,149
1/19/2021	James R. Kasinger	General Counsel	Sell	27,500	$204.94	$5,635,850.00
1/15/2021	Lawrence Otto Klein	COO	Sell	25,000	$215.20	$5,380,000.00	28,666
1/15/2021	Samarth Kulkarni	CEO	Sell	20,000	$213.67	$4,273,400.00	202,989
12/21/2020	Tony W. Ho	VP	Sell	23,551	$149.23	$3,514,515.73
12/16/2020	Bradley J. Bolzon	Director	Sell	7,648	$148.95	$1,139,169.60	6,734
12/10/2020	Bradley J. Bolzon	Director	Sell	33,000	$143.35	$4,730,550.00	40,648
12/10/2020	Samarth Kulkarni	CEO	Sell	20,000	$142.29	$2,845,800.00	189,189
12/7/2020	Bradley J. Bolzon	Director	Sell	171,004	$154.53	$26,425,248.12	40,648
11/30/2020	Rodger Novak	President	Sell	100,000	$125.00	$12,500,000.00	698,007

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for CRISPR Therapeutics (NASDAQ:CRSP)

68.20% of CRISPR Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

CRISPR Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/28/2023	IMA Wealth Inc.	25,517	$1.16M	0.3%	-1.0%	0.032%
11/16/2023	Integrated Advisors Network LLC	7,203	$0.33M	0.0%	N/A	0.009%
11/16/2023	Creative Planning	14,950	$0.68M	0.0%	+61.7%	0.019%
11/16/2023	Spouting Rock Asset Management LLC	10,008	$0.45M	0.1%	-30.0%	0.013%
11/16/2023	Front Row Advisors LLC	836	$38K	0.0%	-95.0%	0.001%
11/16/2023	Penserra Capital Management LLC	4,884	$0.22M	0.0%	+26.5%	0.006%
11/15/2023	WealthPlan Investment Management LLC	9,375	$0.43M	0.1%	+16,063.8%	0.012%
11/15/2023	Mercer Global Advisors Inc. ADV	10,985	$0.50M	0.0%	+3.7%	0.014%
11/15/2023	The Manufacturers Life Insurance Company	29,393	$1.33M	0.0%	+31.2%	0.037%
11/15/2023	Royal Bank of Canada	96,935	$4.40M	0.0%	-2.1%	0.122%
11/15/2023	Schroder Investment Management Group	125,013	$5.67M	0.0%	-1.4%	0.157%
11/15/2023	Scotia Capital Inc.	9,216	$0.42M	0.0%	-4.3%	0.012%
11/15/2023	Sei Investments Co.	55,455	$2.52M	0.0%	-4.2%	0.070%
11/15/2023	Seven Eight Capital LP	16,179	$0.73M	0.1%	N/A	0.020%
11/15/2023	JPMorgan Chase & Co.	520,429	$23.62M	0.0%	-5.6%	0.655%
11/15/2023	Legal & General Group Plc	67,150	$3.05M	0.0%	+4.2%	0.085%
11/15/2023	Ameriprise Financial Inc.	115,374	$5.23M	0.0%	-10.8%	0.145%
11/15/2023	Armistice Capital LLC	600,012	$27.24M	0.4%	+20.0%	0.755%
11/15/2023	Axxcess Wealth Management LLC	7,781	$0.35M	0.0%	-12.6%	0.010%
11/15/2023	Advisors Asset Management Inc.	7,218	$0.33M	0.0%	+26.4%	0.009%
11/14/2023	Lazard Asset Management LLC	115,514	$5.24M	0.0%	-2.8%	0.145%
11/14/2023	Corton Capital Inc.	5,409	$0.25M	0.1%	+6.1%	0.007%
11/14/2023	Ancora Advisors LLC	1,330	$60K	0.0%	+111.1%	0.002%
11/14/2023	Itau Unibanco Holding S.A.	2,521	$0.11M	0.0%	+10.8%	0.003%
11/14/2023	California State Teachers Retirement System	66,308	$3.01M	0.0%	+0.9%	0.083%
11/14/2023	Tower Research Capital LLC TRC	4,271	$0.19M	0.0%	-68.8%	0.005%
11/14/2023	Qube Research & Technologies Ltd	3,698	$0.17M	0.0%	-17.9%	0.005%
11/14/2023	Westfield Capital Management Co. LP	297,550	$13.51M	0.1%	N/A	0.375%
11/14/2023	Merlin Capital Inc	9,092	$0.41M	1.5%	+3.3%	0.011%
11/14/2023	Profund Advisors LLC	29,268	$1.33M	0.1%	+21.5%	0.037%
11/13/2023	C M Bidwell & Associates Ltd.	3,119	$0.14M	0.1%	+28.7%	0.004%
11/13/2023	Natixis Advisors L.P.	11,707	$0.53M	0.0%	-2.6%	0.015%
11/13/2023	Jaffetilchin Investment Partners LLC	4,949	$0.23M	0.0%	+19.6%	0.006%
11/13/2023	Northern Trust Corp	244,248	$11.09M	0.0%	+2.1%	0.308%
11/13/2023	Federated Hermes Inc.	508,100	$23.06M	0.1%	-0.1%	0.640%
11/13/2023	Stifel Financial Corp	26,879	$1.22M	0.0%	-6.9%	0.034%
11/13/2023	Mariner LLC	7,490	$0.34M	0.0%	+14.3%	0.009%
11/13/2023	Interchange Capital Partners LLC	5,765	$0.26M	0.2%	+6.1%	0.007%
11/13/2023	Invesco Ltd.	136,123	$6.18M	0.0%	+1.5%	0.171%
11/13/2023	FMR LLC	2,057,414	$93.39M	0.0%	-1.6%	2.590%
11/13/2023	Envestnet Asset Management Inc.	28,620	$1.30M	0.0%	+58.9%	0.036%
11/13/2023	Nordea Investment Management AB	108,100	$5.04M	0.0%	+13.4%	0.136%
11/13/2023	Envestnet Portfolio Solutions Inc.	4,427	$0.20M	0.0%	N/A	0.006%
11/13/2023	Rafferty Asset Management LLC	189,387	$8.60M	0.1%	+28.9%	0.238%
11/13/2023	Baillie Gifford & Co.	441,063	$20.02M	0.0%	+81.1%	0.555%
11/13/2023	Kestra Advisory Services LLC	5,628	$0.26M	0.0%	-7.7%	0.007%
11/13/2023	Bank Julius Baer & Co. Ltd Zurich	19,856	$0.90M	0.0%	+208.4%	0.025%
11/13/2023	PNC Financial Services Group Inc.	6,808	$0.31M	0.0%	+159.4%	0.009%
11/13/2023	E Fund Management Co. Ltd.	9,157	$0.42M	0.0%	+25.5%	0.012%
11/9/2023	Loomis Sayles & Co. L P	1,096,354	$49.76M	0.1%	-4.5%	1.381%
11/9/2023	Oliver Lagore Vanvalin Investment Group	612	$28K	0.0%	-24.9%	0.001%
11/9/2023	Citigroup Inc.	112,111	$5.09M	0.0%	+3.3%	0.141%
11/9/2023	Headlands Technologies LLC	754	$34K	0.0%	N/A	0.001%
11/9/2023	Mitsubishi UFJ Trust & Banking Corp	48,520	$2.20M	0.0%	+65.7%	0.061%
11/8/2023	Van ECK Associates Corp	72,830	$3.31M	0.0%	-5.1%	0.092%
11/8/2023	Charles Schwab Investment Management Inc.	637,938	$28.96M	0.0%	-1.4%	0.803%
11/8/2023	Janney Montgomery Scott LLC	13,087	$0.59M	0.0%	+83.7%	0.016%
11/8/2023	Spire Wealth Management	1,052	$48K	0.0%	+32.7%	0.001%
11/8/2023	Swiss National Bank	164,800	$7.48M	0.0%	+1.3%	0.208%
11/8/2023	Value Star Asset Management Hong Kong Ltd	17,650	$0.80M	0.3%	N/A	0.022%
11/8/2023	Oppenheimer & Co. Inc.	21,998	$1M	0.0%	+15.6%	0.028%
11/7/2023	Cutler Group LLC CA	2,000	$90K	0.0%	-30.1%	0.003%
11/7/2023	Barclays PLC	510,832	$23.19M	0.0%	+36.9%	0.643%
11/7/2023	Fox Run Management L.L.C.	4,511	$0.21M	0.1%	-34.0%	0.006%
11/7/2023	Jump Financial LLC	33,307	$1.51M	0.1%	+194.7%	0.042%
11/7/2023	Arizona State Retirement System	21,351	$0.97M	0.0%	+1.7%	0.027%
11/6/2023	Privium Fund Management B.V.	7,200	$0.33M	0.1%	+20.0%	0.009%
11/4/2023	Signaturefd LLC	2,124	$96K	0.0%	+12.5%	0.003%
11/3/2023	Liberty One Investment Management LLC	3,376	$0.15M	0.0%	-7.5%	0.004%
11/3/2023	Loring Wolcott & Coolidge Fiduciary Advisors LLP MA	1,035	$48K	0.0%	+137.9%	0.001%
11/3/2023	SteelPeak Wealth LLC	5,780	$0.26M	0.0%	+14.6%	0.007%
11/3/2023	Private Advisor Group LLC	5,654	$0.25M	0.0%	+12.3%	0.007%
11/3/2023	Lincoln Capital Corp	4,500	$0.20M	0.1%	N/A	0.006%
11/2/2023	EFG Asset Management North America Corp.	82,672	$3.75M	0.9%	+10.3%	0.104%
11/2/2023	California Public Employees Retirement System	112,169	$5.09M	0.0%	+5.9%	0.141%
11/2/2023	Capital Investment Advisory Services LLC	30,781	$1.40M	0.1%	+3.1%	0.039%
11/2/2023	FDx Advisors Inc.	6,328	$0.29M	0.0%	-21.7%	0.008%
11/1/2023	Congress Asset Management Co. MA	40,260	$1.83M	0.0%	N/A	0.051%
11/1/2023	Jacob Asset Management of New York LLC	4,003	$0.18M	0.3%	+10.8%	0.005%
10/31/2023	Teacher Retirement System of Texas	21,284	$0.97M	0.0%	+5.0%	0.027%
10/31/2023	Hedges Asset Management LLC	22,525	$1.02M	0.9%	+18.9%	0.028%
10/31/2023	China Universal Asset Management Co. Ltd.	2,041	$93K	0.0%	+97.4%	0.003%
10/30/2023	Tradewinds Capital Management LLC	710	$32K	0.0%	+545.5%	0.001%
10/30/2023	Del Sette Capital Management LLC	33,977	$1.54M	1.5%	+0.9%	0.043%
10/30/2023	Arete Wealth Advisors LLC	11,601	$0.53M	0.1%	+8.1%	0.015%
10/30/2023	Perigon Wealth Management LLC	14,309	$0.65M	0.0%	+25.7%	0.018%
10/30/2023	Sumitomo Mitsui Trust Holdings Inc.	3,465,470	$157.30M	0.1%	-1.9%	4.364%
10/27/2023	Hennion & Walsh Asset Management Inc.	15,315	$0.70M	0.0%	+89.5%	0.019%
10/27/2023	Allspring Global Investments Holdings LLC	287,394	$13.05M	0.0%	-12.0%	0.362%
10/27/2023	First Horizon Advisors Inc.	1,555	$71K	0.0%	-25.8%	0.002%
10/27/2023	TD Asset Management Inc	240,462	$10.92M	0.0%	+12.9%	0.303%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	184,854	$8.39M	0.0%	+10.3%	0.233%
10/25/2023	BluePath Capital Management LLC	825	$37K	0.0%	N/A	0.001%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	18,527	$0.84M	0.0%	+11.3%	0.023%
10/25/2023	Intellectus Partners LLC	8,556	$0.39M	0.1%	+8.2%	0.011%
10/24/2023	Bank of New York Mellon Corp	105,415	$4.79M	0.0%	-2.5%	0.133%
10/24/2023	Independent Advisor Alliance	15,256	$0.69M	0.0%	+327.2%	0.019%
10/24/2023	Stratos Wealth Advisors LLC	10,561	$0.48M	0.0%	+86.1%	0.013%
10/24/2023	Stratos Wealth Partners LTD.	5,580	$0.25M	0.0%	+28.2%	0.007%
10/24/2023	Capital Advisors Inc. OK	231,925	$10.53M	0.3%	+7.4%	0.292%

Data available starting January 2016

CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.

Today's Range

Now: $69.09

$68.93

$73.55

50 Day Range

MA: $50.00

$38.62

$72.18

52 Week Range

Now: $69.09

$37.55

$76.19

Volume

2,213,156 shs

Average Volume

1,345,020 shs

Market Capitalization

$5.49 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57

Who are the company insiders with the largest holdings of CRISPR Therapeutics?: CRISPR Therapeutics' top insider shareholders include:
Samarth Kulkarni (CEO)
Learn More about top insider investors at CRISPR Therapeutics.
Who are the major institutional investors of CRISPR Therapeutics?: CRISPR Therapeutics' top institutional shareholders include:
ARK Investment Management LLC — 9.02%
Sumitomo Mitsui Trust Holdings Inc. — 4.36%
FMR LLC — 2.59%
Loomis Sayles & Co. L P — 1.38%
Charles Schwab Investment Management Inc. — 0.80%
Armistice Capital LLC — 0.76%
Learn More about top institutional investors of CRISPR Therapeutics stock.
Which institutional investors are selling CRISPR Therapeutics stock?: During the previous quarter, CRSP stock was sold by these institutional investors:
ARK Investment Management LLC
Sumitomo Mitsui Trust Holdings Inc.
Loomis Sayles & Co. L P
Allspring Global Investments Holdings LLC
FMR LLC
JPMorgan Chase & Co.
Group One Trading L.P.
IMC Chicago LLC
Which institutional investors are buying CRISPR Therapeutics stock?: Within the previous quarter, CRSP stock was bought by institutional investors including:
Westfield Capital Management Co. LP
Baillie Gifford & Co.
Barclays PLC
Armistice Capital LLC
GTS Securities LLC
Baker Chad R
Rafferty Asset Management LLC
Congress Asset Management Co. MA

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

CRSP Insider Trading

CRISPR Therapeutics Insider Trading History Chart

CRISPR Therapeutics Share Price & Price History

CRISPR Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for CRISPR Therapeutics (NASDAQ:CRSP)

Institutional Buying and Selling by Quarter

CRISPR Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of CRISPR Therapeutics?

Who are the major institutional investors of CRISPR Therapeutics?

Which institutional investors are selling CRISPR Therapeutics stock?

Which institutional investors are buying CRISPR Therapeutics stock?